Featured insights

The latest at the Foundation

Insights from our industry-shifting research and analysis, coverage in the international media, events, and all the latest from the Access to Medicine Foundation.

News

New methodology paves the way for the Foundation's 2026 AMR Benchmark

28 January 2025

News

Pharma companies still not maximising their potential to reach more patients in low- and middle-income countries

19 November 2024

News

Foundation's new report reveals what pharma companies can do to ensure their products reach underserved populations

10 September 2024

Foundation's new report narrows in on critical gaps in diabetes care faced by children and young people – identifying opportunities for pharma to scale access

13 May 2025

Resource Center

Explore our research reports and publications

Featured Key findings

Pharma companies are taking steps to address access in low-income countries, but significant gaps remain

19 November 2024

Research

Best practices identified in the 2024 Access to Medicine Index

19 November 2024

Media

Lancet Global Health Commission on Medical Oxygen Security - Over 5 billion people lack medical oxygen access: urgent action needed

17 February 2025

Event

High-level event on enhancing access to essential medicines - Meeting Report

29 October 2024

Event

Foundation and WEF’s joint event on equitable access: Meeting Report

18 June 2024

2024 Ranking

Novartis ranks as the top company for the first time, followed closely by GSK. Sanofi has newly joined the top three. Pfizer joins the top five, and Boehringer Ingelheim rises into the top ten.

Featured Media

Op-ed: Trump aid shock underscores need for more made-in-Africa medicine

06 March 2025

Media

Investors Urged to Prioritise Accessible US Healthcare

31 January 2025

Media

Jayasree K. Iyer unpacks the 2024 Access to Medicine Index findings on CNBC Africa

22 November 2024

Achievements so far

How our research findings trigger change

14 November 2022

Case study

How companies demonstrate movement on key opportunities identified by our research: Sanofi Global Health Unit

10 November 2022

Case study

Pfizer's 'Accord for a Healthier World'

28 October 2022

New methodology paves the way for the Foundation's 2026 AMR Benchmark

Pharma companies still not maximising their potential to reach more patients in low- and middle-income countries

Foundation's new report reveals what pharma companies can do to ensure their products reach underserved populations

Foundation's new report narrows in on critical gaps in diabetes care faced by children and young people – identifying opportunities for pharma to scale access

Resource Center

Pharma companies are taking steps to address access in low-income countries, but significant gaps remain

Best practices identified in the 2024 Access to Medicine Index

Lancet Global Health Commission on Medical Oxygen Security​ - Over 5 billion people lack medical oxygen access: urgent action needed

High-level event on enhancing access to essential medicines - Meeting Report

Foundation and WEF’s joint event on equitable access: Meeting Report

Novartis ranks as the top company for the first time, followed closely by GSK. Sanofi has newly joined the top three. Pfizer joins the top five, and Boehringer Ingelheim rises into the top ten.

Op-ed: Trump aid shock underscores need for more made-in-Africa medicine

Investors Urged to Prioritise Accessible US Healthcare

Jayasree K. Iyer unpacks the 2024 Access to Medicine Index findings on CNBC Africa

Achievements so far

How our research findings trigger change

How companies demonstrate movement on key opportunities identified by our research: Sanofi Global Health Unit

Pfizer's 'Accord for a Healthier World'

Lancet Global Health Commission on Medical Oxygen Security - Over 5 billion people lack medical oxygen access: urgent action needed